Pharmacokinetics, pharmacodynamics, safety, and tolerability of single-dose fingolimod (FTY720) in adolescents with stable renal transplants.
about
Lymphatic disorders after renal transplantation: new insights for an old complicationA systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.Clinical pharmacokinetics of fingolimod.PKR negatively regulates leukemia progression in association with PP2A activation, Bcl-2 inhibition and increased apoptosis.
P2860
Pharmacokinetics, pharmacodynamics, safety, and tolerability of single-dose fingolimod (FTY720) in adolescents with stable renal transplants.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pharmacokinetics, pharmacodyna ...... with stable renal transplants.
@en
Pharmacokinetics, pharmacodyna ...... with stable renal transplants.
@nl
type
label
Pharmacokinetics, pharmacodyna ...... with stable renal transplants.
@en
Pharmacokinetics, pharmacodyna ...... with stable renal transplants.
@nl
prefLabel
Pharmacokinetics, pharmacodyna ...... with stable renal transplants.
@en
Pharmacokinetics, pharmacodyna ...... with stable renal transplants.
@nl
P2093
P2860
P1476
Pharmacokinetics, pharmacodyna ...... with stable renal transplants.
@en
P2093
J M Kovarik
M C Bastien
R Ettenger
R Schmouder
P2860
P304
P356
10.1111/J.1399-3046.2011.01498.X
P577
2011-06-01T00:00:00Z